Phenprocoumon

Phenprocoumon

Clinical data
ATC code	B01AA04 (WHO)
Pharmacokinetic data
Protein binding	99%
Metabolism	hepatic to inactive metabolites
Elimination half-life	5 to 6 days
Identifiers
IUPAC name 2-hydroxy-3-(1-phenylpropyl)chromen-4-one
CAS Number	435-97-2
PubChem CID	9908
DrugBank	APRD00228
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C18H16O3
Molar mass	280.318 g/mol

WikiDoc Resources for Phenprocoumon
Articles
Most recent articles on Phenprocoumon Most cited articles on Phenprocoumon Review articles on Phenprocoumon Articles on Phenprocoumon in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Phenprocoumon Images of Phenprocoumon Photos of Phenprocoumon Podcasts & MP3s on Phenprocoumon Videos on Phenprocoumon
Evidence Based Medicine
Cochrane Collaboration on Phenprocoumon Bandolier on Phenprocoumon TRIP on Phenprocoumon
Clinical Trials
Ongoing Trials on Phenprocoumon at Clinical Trials.gov Trial results on Phenprocoumon Clinical Trials on Phenprocoumon at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Phenprocoumon NICE Guidance on Phenprocoumon NHS PRODIGY Guidance FDA on Phenprocoumon CDC on Phenprocoumon
Books
Books on Phenprocoumon
News
Phenprocoumon in the news Be alerted to news on Phenprocoumon News trends on Phenprocoumon
Commentary
Blogs on Phenprocoumon
Definitions
Definitions of Phenprocoumon
Patient Resources / Community
Patient resources on Phenprocoumon Discussion groups on Phenprocoumon Patient Handouts on Phenprocoumon Directions to Hospitals Treating Phenprocoumon Risk calculators and risk factors for Phenprocoumon
Healthcare Provider Resources
Symptoms of Phenprocoumon Causes & Risk Factors for Phenprocoumon Diagnostic studies for Phenprocoumon Treatment of Phenprocoumon
Continuing Medical Education (CME)
CME Programs on Phenprocoumon
International
Phenprocoumon en Espanol Phenprocoumon en Francais
Business
Phenprocoumon in the Marketplace Patents on Phenprocoumon
Experimental / Informatics
List of terms related to Phenprocoumon

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Phenprocoumon is an anticoagulant, functioning as a Vitamin K antagonist. It is a derivative of coumarin and is also marketed under the brand name Marcoumar. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders.

It is marketed as Marcoumar by Roche.

External links

• Template:DiseasesDB